
|Articles|May 28, 2009
Ranbaxy chief steps down
1 June 2009
Advertisement
Chairman and chief executive of Ranbaxy Laboratories, Malvinder Singh, has stepped down, handing more control over the generic drug maker to its Japanese owner Daiichi Sankyo.
Mr Singh's family founded the company and it has since become one of India's best-known multinational companies. He will be replaced as chief executive by Atul Sobti, currently the company's chief operating officer and Tsutomo Une, Daiichi's senior executive officer, will take over his responsibilities as chairman.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
5




